![Palbociclib and hormonal therapy has proven progression-free survival benefit](https://www.hoaallc.com/wp-content/uploads/2016/11/HOAA-Breast-Cancer-News.jpg)
In hormone-positive metastatic breast cancer, combination therapy with palbociclib and hormonal therapy has proven progression-free survival benefit Palbociclib is an oral drug that inhibits cell cycle growth by blocking cells from initiating initial switch to the growth cycle of cells though CDK4 (Cyclin D-Dependent Kinase) and CDK 6 inhibition. This drug has been found to… Read more »